Addressing solid tumours and the upcoming clinical trial of natural killer (NK) cell therapy for ovarian cancer

Cartherics’ CEO, Prof. Alan Trounson AO recently presented at Private Capital 2024 held at the ASX Building in Sydney. During his presentation, Alan delves into Cartherics‘ pioneering technology for addressing solid tumours and the upcoming clinical trial of its natural killer (NK) cell therapy for ovarian cancer. Watch it here:

https://www.youtube.com/watch?v=GhUzfuck4xA